Aktiespot

null (EMCURE PHARMACEUTICALS L) aktie

EMCURE.NS

₹1,719.60-37.20 (-2.12%)
Laddar diagram...

EMCURE PHARMACEUTICALS L

Öppning1,756.80
Högsta1,792.00
Lägsta1,711.60
Volym173.84k
P/E35.21
Börsvärde326.14B
52 veckors högsta1,830.00
52 veckors lägsta1,228.90
Genomsnittlig volym267.97k
Utdelning0.17%
BetaN/A
EPS48.84

Om null (EMCURE PHARMACEUTICALS L) aktie

Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide. It offers products in various therapeutic areas, such gynecology, anti-infectives, pain/analgesics, Vitamins, Minerals & Nutrients, blood-related, oncology, respiratory, HIV antivirals, gastro, anti-diabetic, neuro, and cardiovascular. It provides its products under Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym brand names. Emcure Pharmaceuticals Limited has a strategic partnership with Novo Nordisk India Pvt Ltd. for the development and commercialization of Poviztra, a semaglutide injection for weight loss. Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.

Företagsinformation

Börs: NSE (NSI)
Sektor: Sundhed
Industri: Lægemiddelproducenter – Special og generisk
Adress:
Plot No. P-1 and P-2
411057 Pune, India
Telefon: + 91 20 3507 0033

Analytikernas aktierekommendationer

Denna översikt ger en snabb insikt i hur analytiker bedömer aktiens potential baserat på deras senaste analyser och kursmål.

Lägsta kursmål
1,640.00
4.6%
Genomsnittligt kursmål
1,891.83
10.0%
Median kursmål
1,945.00
13.1%
Högsta kursmål
1,976.00
14.9%

Andra tittar också på: